Oncodesign Precision Medicine S.A Logo

Oncodesign Precision Medicine S.A

ISIN

FR001400CM63

Ticker

ALOPM

Sector

Health Care

Sub-Industry

Biotechnology

Country

France

Year Founded

2020

About Oncodesign Precision Medicine S.A

Company Description

OPM is a technological company specialized in precision medicine.

OPM's mission is to bring innovative therapeutic and diagnostic solutions to treat therapeutic resistance and metastasis evolution. The patient is at the centre of our reflexion, of our unique innovative model, and our investments.

For OPM "our collective success is paramount", there can be no value creation without exchange, without dialogue. The value creation resulting for us from reciprocity, i.e. balanced and fair exchanges at all levels, whether between internal collaborators, or with our partners, therapists, patients, experts and investors.

Served Area

Worldwide

Headquarters

18 rue Jean Mazen
21000, Dijon
France

Capital Markets Information

ISIN

FR001400CM63

LEI

969500ZDX1IY47LDL876

Sub-Industry

Biotechnology

Listed Stock Exchange

Euronext Paris

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.